Italia markets closed

Progyny, Inc. (PGNY)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
38,15+0,16 (+0,42%)
Alla chiusura: 04:00PM EDT
38,15 0,00 (0,00%)
Dopo ore: 04:10PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente37,99
Aperto37,91
Denaro38,09 x 200
Lettera38,17 x 100
Min-Max giorno37,91 - 38,98
Intervallo di 52 settimane29,44 - 44,95
Volume670.184
Media Volume813.944
Capitalizzazione3,681B
Beta (5 anni mensile)1,48
Rapporto PE (ttm)61,53
EPS (ttm)0,62
Prossima data utili06 mag 2024 - 10 mag 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A46,67
  • GlobeNewswire

    Progyny Celebrates More Than 30,000 Amazonians Supported on Their Family Building Journeys

    Amazon’s comprehensive family building benefit offered through Progyny to be recognized at RESOLVE’s Night of Hope GalaNEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced their nearly five-year partnership with Amazon has reached a milestone number of more than 30,000 individuals and families being supported on their family building journeys. Since 2019, A

  • GlobeNewswire

    Progyny Unveils Nationwide Access to Menopause Care

    Integrative approach with leading providers Gennev and Midi Health to advance equitable and accessible workplace support for individuals experiencing menopause symptomsNEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced the strategic expansion of its extensive managed reproductive health network to include specialized providers of menopause care. Progyny’s

  • GlobeNewswire

    Progyny, Inc. Announces Second Quarter 2023 Results

    Reports Record Quarterly Revenue of $279.4 Million, Reflecting 43% Growth Over the Prior Year PeriodAchieves Record Quarterly Operating Cash Flow of $76.0 MillionRaises Full Year Revenue and Earnings GuidanceContinuing to See Strong Employer Demand for Fertility and Family Building Solutions NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions,